Are Circulating Tumor Cells (CTCs) Ready for Clinical Use in Breast Cancer? An Overview of Completed and Ongoing Trials Using CTCs for Clinical Treatment Decisions

Are Circulating Tumor Cells (CTCs) Ready for Clinical Use in Breast Cancer? An Overview of Completed and Ongoing Trials Using CTCs for Clinical Treatment Decisions

In recent years, breast cancer treatment has become increasingly individualized. Circulating tumor cells (CTCs) have the potential to move personalized medicine another step forward. The prognostic relevance of CTCs has already been proven both in early and metastatic breast cancer. In addition, the...

Full description

Bibliographic Details
Main Authors:	Fabienne Schochter, Thomas W. P. Friedl, Amelie deGregorio, Sabrina Krause, Jens Huober, Brigitte Rack, Wolfgang Janni
Format:	Article
Language:	English
Published:	MDPI AG 2019-11-01
Series:	Cells
Subjects:	circulating tumor cells (ctcs) clinical trials breast cancer ctc-based treatment decisions
Online Access:	https://www.mdpi.com/2073-4409/8/11/1412

Similar Items

CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs)
by: Tala Tayoun, et al.
Published: (2019-09-01)

Dangerous Liaisons: Circulating Tumor Cells (CTCs) and Cancer-Associated Fibroblasts (CAFs)
by: Pablo Hurtado, et al.
Published: (2020-10-01)

Recent Progress in Enhanced Cancer Diagnosis, Prognosis, and Monitoring Using a Combined Analysis of the Number of Circulating Tumor Cells (CTCs) and Other Clinical Parameters
by: Thi Ngoc Anh Nguyen, et al.
Published: (2023-11-01)

CtcS, a MarR family regulator, regulates chlortetracycline biosynthesis
by: Lingxin Kong, et al.
Published: (2019-12-01)

Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer
by: Andrew A. Davis, et al.
Published: (2019-12-01)

Potential Use of CTCs as Biomarkers in Renal Cancer Patients
by: Joanna Bialek, et al.
Published: (2022-01-01)

The Mechanical Fingerprint of Circulating Tumor Cells (CTCs) in Breast Cancer Patients
by: Ivonne Nel, et al.
Published: (2021-03-01)

Gauging the Impact of Cancer Treatment Modalities on Circulating Tumor Cells (CTCs)
by: Trevor J. Mathias, et al.
Published: (2020-03-01)

Required Evidence for Clinical Applications of Liquid Biopsy Using Especially CTCs in Lung Cancer
by: Menno Tamminga, et al.
Published: (2020-05-01)

Diagnosis of Prostate Cancer, from Conventional Methods Towards the New Promising CTCs
by: M. Shahrabi-Farahani, et al.
Published: (2016-02-01)

Emerging Lab-on-a-Chip Approaches for Liquid Biopsy in Lung Cancer: Status in CTCs and ctDNA Research and Clinical Validation
by: Ângela Carvalho, et al.
Published: (2021-04-01)

Tumor‐derived proliferative CTCs and CTC clusters predict aggressiveness and early recurrence in hepatocellular carcinoma patients
by: Lina Zhao, et al.
Published: (2023-07-01)

CTCs 2020: Great Expectations or Unreasonable Dreams
by: Elisabetta Rossi, et al.
Published: (2019-08-01)

A label-free microfluidic chip for the highly selective isolation of single and cluster CTCs from breast cancer patients
by: Xiaofen Zhang, et al.
Published: (2021-01-01)

Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design
by: Zdeněk Kejík, et al.
Published: (2021-11-01)

Molecular Interplay between Dormant Bone Marrow-Resident Cells (BMRCs) and CTCs in Breast Cancer
by: Debasish Boral, et al.
Published: (2020-06-01)

Evaluation of α-tubulin, detyrosinated α-tubulin, and vimentin in CTCs: identification of the interaction between CTCs and blood cells through cytoskeletal elements
by: G. Kallergi, et al.
Published: (2018-07-01)

Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions
by: Zhuo eZhang, et al.
Published: (2015-09-01)

Deep Phenotypic Characterisation of CTCs by Combination of Microfluidic Isolation (IsoFlux) and Imaging Flow Cytometry (ImageStream)
by: Antonio J. Ruiz-Rodríguez, et al.
Published: (2021-12-01)

Detection of Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM) with the “Universal” CTC-Chip and An Anti-Podoplanin Antibody NZ-1.2
by: Taiji Kuwata, et al.
Published: (2020-04-01)

Programmable materials for efficient CTCs isolation: From micro/nanotechnology to biomimicry
by: Jianwen Hou, et al.
Published: (2021-12-01)

Short-Term Ex Vivo Culture of CTCs from Advance Breast Cancer Patients: Clinical Implications
by: Nuria Carmona-Ule, et al.
Published: (2021-05-01)

Design of a Hybrid Inertial and Magnetophoretic Microfluidic Device for CTCs Separation from Blood
by: Rohollah Nasiri, et al.
Published: (2021-07-01)

Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
by: Zachery R. Reichert, et al.
Published: (2021-12-01)

Evaluation of Isolation Methods for Circulating Tumor Cells (CTCs)
by: Galatea Kallergi, et al.
Published: (2016-11-01)

The prognostic value of JUNB-positive CTCs in metastatic breast cancer: from bioinformatics to phenotypic characterization
by: Galatea Kallergi, et al.
Published: (2019-08-01)

Exploring the Role of Hypoxia-Inducible Carbonic Anhydrase IX (CAIX) in Circulating Tumor Cells (CTCs) of Breast Cancer
by: Julianne D. Twomey, et al.
Published: (2023-03-01)

The propensity of invasive circulating tumor cells (iCTCs) in metastatic progression and therapeutic responsiveness
by: Huan Dong, et al.
Published: (2019-07-01)

Development of a Microfluidic-Based Optical Sensing Device for Label-Free Detection of Circulating Tumor Cells (CTCs) Through Their Lactic Acid Metabolism
by: Tzu-Keng Chiu, et al.
Published: (2015-03-01)

The prognostic value of circulating tumour cells (CTCs) and CTC white blood cell clusters in patients with renal cell carcinoma
by: Yibing Guan, et al.
Published: (2021-07-01)

Detection of EGFR Mutations in Plasma cfDNA and Paired CTCs of NSCLC Patients before and after Osimertinib Therapy Using Crystal Digital PCR
by: Aliki Ntzifa, et al.
Published: (2021-05-01)

Correlation between PD-L1 expression ON CTCs and prognosis of patients with cancer: a systematic review and meta-analysis
by: Defeng Kong, et al.
Published: (2021-01-01)

Correlation Between Circulating Tumor Cell DNA Genomic Alterations and Mesenchymal CTCs or CTC-Associated White Blood Cell Clusters in Hepatocellular Carcinoma
by: Chunming Wang, et al.
Published: (2021-06-01)

Sequential Isolation and Characterization of Single CTCs and Large CTC Clusters in Metastatic Colorectal Cancer Patients
by: Federica Francescangeli, et al.
Published: (2021-12-01)

Reliability analysis on the train control system in the CTCS-3 operating mode
by: Lijuan Shi, et al.
Published: (2021-05-01)

Cancer Stem Cells (CSCs), Circulating Tumor Cells (CTCs) and Their Interplay with Cancer Associated Fibroblasts (CAFs): A New World of Targets and Treatments
by: Beatrice Aramini, et al.
Published: (2022-05-01)

Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis—Results from the Adjuvant SUCCESS A Trial
by: Elisabeth K. Trapp, et al.
Published: (2022-08-01)

Circulating miR-200 Family and CTCs in Metastatic Breast Cancer before, during, and after a New Line of Systemic Treatment
by: Chiara Fischer, et al.
Published: (2022-08-01)

Investigating the Role of CTCs with Stem/EMT-like Features in Metastatic Breast Cancer Patients Treated with Eribulin Mesylate
by: Maria A. Papadaki, et al.
Published: (2022-08-01)

Circulating tumor cells (CTCs) and hTERT gene expression in CTCs for radiotherapy effect with lung cancer
by: Ying Xu, et al.
Published: (2023-05-01)